Exelixis
EXEL
#1730
Rank
NZ$17.09 B
Marketcap
$61.07
Share price
1.48%
Change (1 day)
81.26%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company